We performed a retrospective cohort study, using the 2002 Nationwide Inpatient Sample, a national database of hospital inpatient stays, to describe the incidence and epidemiology of endemic mycoses requiring hospitalization. An estimated 332 pediatric and 6003 adult patients with endemic mycoses required hospitalization (4.6 and 28.7 cases per 1 million children and adults, respectively). Crude mortality rates were 5% and 7% among children and adults, respectively.
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The major endemic mycoses that occur in the United States include histoplasmosis (caused by Histoplasma capsulatum var. capsulatum), blastomycosis (Blastomyces dermatitidis), and coccidioidomycosis (Coccidioides immitis). Although they occur primarily in distinct geographic areas, these infections can be found in all regions of the United States and are the most common pulmonary fungal infections in immunocompetent people [1] . It has been estimated that the incidence of coccidioidomycosis has increased in certain states and that there are as many as 300,000 new infections in the United States every year [2, 3] . As many as 50% of exposed persons develop symptoms of infection, which most commonly manifests as a pulmonary process [4] [5] [6] . Extrapulmonary dissemination may also occur, particularly among immunocompromised persons, and often can result in hospitalization and even death [3, 7] .
Data about the current epidemiology of endemic fungal infections in the United States are incomplete, particularly with regard to the more severe cases requiring hospitalization, which may, in some cases, exceed 25% of all such infections [8] . We therefore conducted a study of the epidemiology and outcomes related to endemic mycoses requiring hospitalization among children and adults, using an Agency for Healthcare Quality and Research (AHRQ)-sponsored database of hospital stays during 2002. This comprehensive report may be useful in assessing the rates of endemic mycoses sufficiently severe to require hospitalization, as well as the characteristics of patients with these infections.
Methods. This retrospective cohort study was performed using the Nationwide Inpatient Sample (NIS) 2002, a large database of hospital inpatient stays that was developed by the Healthcare Cost and Utilization Project (HCUP) and sponsored by the AHRQ. NIS 2002 contains information on ∼7 million hospital discharges from ∼1000 hospitals in 35 participating US states [9] . The data were obtained from a 20% stratified sample of all participating short-term, nonfederal, nonrehabilitation general and specialty hospitals in the United States.
Pediatric and adult analyses were performed separately. The US Census definition of adulthood was used to define children (!18 years of age) and adults (у18 years of age). Patients with missing age information were excluded. About 1.4 million pediatric discharges and 6.5 million adult discharges were included in the analysis, yielding national estimates of 6.5 million and 31.3 million discharges, respectively.
The endemic mycoses indigenous to the United States are histoplasmosis, blastomycosis, and coccidioidomycosis. These infections were identified by International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. Cases of histoplasmosis were identified using all valid ICD-9-CM codes between 115.00 and 115.99; cases of blastomycosis, by code 116.0; and cases of coccidioidomycosis, by all valid codes between 114.0 and 114.9. Although paracoccidioidomycosis is not considered endemic in the United States, we also identified any reported cases of this infection, using ICD-9-CM code 116.1, because it has been seen in US travelers returning from regions where it is endemic.
We examined cases by patient age, sex, and race or ethnicity; hospital region (defined by US Census); hospital type; comorbidities; inpatient procedures; duration of stay; and hospital charges. A dichotomous variable was created to indicate the presence of any of the following immunocompromising conditions: solid organ and hematologic malignancies; hematologic or immunologic deficiencies, including sickle cell disease and hereditary anemia; and solid organ or bone marrow transplantation.
All statistical analyses were performed using SAS software, Table 1 shows demographic, clinical, and hospital-related characteristics of children and adults by infection type. Figure  1 shows a series of US maps with regional rates of hospitalized infection, stratified by infection type (histoplasmosis, blastomycosis, and coccidioidomycosis) and age group (children and adults). There were only 2 reported cases of paracoccidioidomycosis in the data set.
The median age was 11 years (interquartile range [IQR], 6-15 years) among all pediatric patients and was 52 years (IQR, 38-67 years) among all adult patients. Seventeen percent of hospitalized children and 13% of hospitalized adults with endemic mycoses had a reported underlying immunocomprom- ising condition. The median duration of hospital stay was 5 days (IQR, 2-12 days) among all children with endemic mycoses and was 6 days (IQR, 3-12 days) among all adults with endemic mycoses. The total hospital charges in 2002 for all children with endemic mycoses was ∼$18 million, whereas the total hospital charges for all adults with endemic mycoses was 1$240 million. The crude mortality rate was 5% among children and 7% among adults with endemic mycoses (table 1) .
Discussion. The rates of hospitalization for a single type of endemic mycosis were as high as 5.3 cases per 1,000,000 US children and 28.7 cases per 1,000,000 US adults, with an even greater burden of all endemic mycoses in regions where multiple species are indigenous. We identified a large burden of hospital charges and a considerable mortality rate among persons requiring hospitalization for endemic mycoses. Given the propensity of these infections to cause significant morbidity and mortality, even among immunocompetent persons, the present report may be useful in informing health care providers about the demographic, clinical, and geographic profile of this important subgroup of infected persons.
In our study, the geographic distribution of cases was primarily consistent with previously described areas of endemicity for these infections. Coccidioidomycosis mostly occurred in the southern and western regions of the country, and histoplasmosis generally occurred in the southern and midwestern states. Blastomycosis, largely found along the Ohio and Mississippi Rivers, occurred primarily in midwestern and southern regions. Notably, the rates for all infections were much higher among adults than children, which is consistent with prior reports except those during times of regional outbreaks [10] [11] [12] [13] .
We identified differences in sex distribution between children and adults with endemic mycoses requiring hospitalization. Females accounted for 52% of pediatric cases and 38% of adult cases. This finding may be the result of age differences in the likelihood of exposure to soil and other harbors of these endemic pathogens. Male and female children may experience similar likelihoods of exposure to these pathogens through recreational activities, whereas adult males may be more likely than adult females to be exposed through occupational activities.
With respect to other patient characteristics, immunocompromising conditions were more prevalent among patients with histoplasmosis than among patients with other infection types. Among patients with histoplasmosis, there was a greater proportion of children than of adults with underlying immunodeficiencies (32% vs. 14%), which may reflect a higher background rate of these conditions among children. Despite this, children with histoplasmosis were more likely than adults to achieve a positive clinical outcome (i.e., discharged alive to home). The higher crude mortality experienced among hospitalized adults with histoplasmosis may reflect a higher risk of mortality due to other comorbid conditions experienced by older patients.
The crude mortality was 5% among hospitalized children with endemic mycoses and 7% among hospitalized adults. The slightly higher rate of mortality among adults than among children may reflect the differing impact of infection among older patients with and without underlying diseases. In addition, 13% of all patients who died were immunocompromised and most likely had an increased risk of mortality independent of fungal infection. The majority (87%) of all patients who died were immunocompetent, which reinforces the incidence data showing that otherwise-healthy persons account for most of the burden of these infections.
Large administrative databases, such as the NIS, offer the unique opportunity to develop nationally representative estimates of infections among hospitalized patients. Several limitations, however, are associated with the use of these data sets. First, the use of ICD-9-CM codes for the detection of cases introduces a potential for misclassification. To our knowledge, there are no prior studies evaluating the sensitivity and specificity of the ICD-9-CM codes for endemic mycoses reported in administrative data sets in comparison with a review of medical charts. Any potential misclassification, though, would likely result in a more conservative estimate of the burden of infections, including total hospital charges.
In summary, this is the first nationally representative report of endemic mycoses requiring hospitalization in both adults and children. Although this study presents only a fraction of the burden of all morbidity and mortality related to endemic mycoses, these findings among cases of infection requiring hospitalization are nonetheless compelling and, it is hoped, informative for the clinical evaluation of patients presenting with respiratory and pulmonary symptoms. Obtaining a patient's complete travel history may be valuable in formulating a differential diagnosis among patients with undiagnosed pulmonary symptoms.
